| Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology–what we know and what we do not know from randomized controlled trials T Welzel, C Winskill, N Zhang, A Woerner, M Pfister Pediatric Rheumatology 19, 1-17, 2021 | 19 | 2021 |
| Understanding efficacy-safety balance of biologics in moderate-to-severe pediatric psoriasis K Golhen, C Winskill, M Theiler, M Buettcher, YH Yeh, N Zhang, T Welzel, ... Frontiers in Medicine 9, 944208, 2022 | 9 | 2022 |
| Genomic and transcriptomic analyses of NF1-mutant melanoma identify potential targeted approach for treatment G Jour, I Illa-Bochaca, M Ibrahim, D Donnelly, K Zhu, EVS de Miera, ... Journal of Investigative Dermatology 143 (3), 444-455. e8, 2023 | 7 | 2023 |
| Value of literature review to inform development and use of biologics in juvenile idiopathic arthritis K Golhen, C Winskill, C Yeh, N Zhang, T Welzel, M Pfister Frontiers in Pediatrics 10, 909118, 2022 | 6 | 2022 |
| Effect of Anti‐VEGF Therapy on the Disease Progression of Neovascular Age‐Related Macular Degeneration: A Systematic Review and Model‐Based Meta‐Analysis KT Luu, J Seal, M Green, C Winskill, M Attar The Journal of Clinical Pharmacology 62 (5), 594-608, 2022 | 5 | 2022 |
| Predictors of Women’s Intentions to Communicate Updated Genetic Test Results to Immediate and Extended Family Members C Winskill, MS Goodman, BM Daly, A Elrick, R Mooney, W Espinel, ... Public Health Genomics 26 (1), 24-34, 2023 | 1 | 2023 |
| Correction to: Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology–what we know and what we do not know from randomized … T Welzel, C Winskill, N Zhang, A Woerner, M Pfister Pediatric Rheumatology 19, 1-1, 2021 | | 2021 |
| Associations between biomarker status (amyloid, tau) and risk for progression to MCI/Dementia in the Harvard Aging Brain Study KV Papp, DM Rentz, C Winskill, RA Betensky, RE Amariglio, AP Schultz, ... Alzheimer's & Dementia 17, e056231, 2021 | | 2021 |
| Predictors of women’s intention to communicate genetic test results to relatives C Winskill, K Kaphingst, M Goodman APHA 2021 Annual Meeting and Expo, 2021 | | 2021 |
| Early life factors in eosinophilic esophagitis: A systematic review and meta-analysis E Wilder, C Winskill, Y Jia, P He, R Betensky, A Khan, F Francois, ... NEUROGASTROENTEROLOGY AND MOTILITY 33, 2021 | | 2021 |
| CDC20 is a novel potential therapeutic target in NF1-mutant melanoma. DM Donnelly, KM Giles, E Vega-Saenz de Miera, R Betensky, C Winskill, ... Journal of Clinical Oncology 38 (15_suppl), e22075-e22075, 2020 | | 2020 |
